Literature DB >> 18670420

OGTT-derived measures of insulin sensitivity are confounded by factors other than insulin sensitivity itself.

Katrin Hücking1, Richard M Watanabe, Darko Stefanovski, Richard N Bergman.   

Abstract

Insulin resistance is an important risk factor for diabetes and other diseases. It has been important to estimate insulin resistance in epidemiological and genetic studies involving significant number of individuals. Complex and invasive protocols are impractical. Therefore, insulin sensitivity indices based on the oral glucose-tolerance test (OGTT) have been introduced. The aim of the present study was to assess the accuracy with which OGTT-derived indices would reflect changes in insulin sensitivity in the face of changes in other factors, such as rate of glucose absorption and/or B-cell function. A computer model was employed to predict excursions of plasma glucose and insulin after a 75-g oral glucose load. The model was then used to predict changes in these excursions, which would be observed with altered insulin resistance, with alterations in beta-cell sensitivity to glucose and/or alterations in glucose absorption rates. Published indices of insulin sensitivity could then be calculated from the predicted curves, to ask whether changes in beta-cell function or glucose absorptions rates might be misinterpreted (using the indices) as changes in insulin sensitivity. The model accurately represented OGTT data for a normal glucose tolerant subject, closely matching published data. Imposed 50% reductions or increases in insulin sensitivity alone in the model were reflected in only small changes in OGTT-derived insulin sensitivity values. More important, imposed alterations in beta-cell sensitivity and glucose absorption without simulated changes in insulin sensitivity did change insulin sensitivity indices. These results indicate that caution is required for the interpretation of differences in OGTT-derived values of insulin sensitivity, because variation in factors other than insulin sensitivity per se appear to have the greatest effects on indices calculated from the OGTT alone.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18670420      PMCID: PMC3417105          DOI: 10.1038/oby.2008.336

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  34 in total

1.  Novel insulin sensitivity index derived from oral glucose tolerance test.

Authors:  Supamai Soonthornpun; Worawong Setasuban; Atchara Thamprasit; Wanne Chayanunnukul; Chatchalit Rattarasarn; Alan Geater
Journal:  J Clin Endocrinol Metab       Date:  2003-03       Impact factor: 5.958

2.  Insulin release and peripheral sensitivity at the oral glucose tolerance test.

Authors:  J Cederholm; L Wibell
Journal:  Diabetes Res Clin Pract       Date:  1990-10       Impact factor: 5.602

3.  Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects.

Authors:  M Horowitz; M A Edelbroek; J M Wishart; J W Straathof
Journal:  Diabetologia       Date:  1993-09       Impact factor: 10.122

4.  Effect of insulin on the distribution and disposition of glucose in man.

Authors:  E Ferrannini; J D Smith; C Cobelli; G Toffolo; A Pilo; R A DeFronzo
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

5.  Minimal model-based insulin sensitivity has greater heritability and a different genetic basis than homeostasis model assessment or fasting insulin.

Authors:  Richard N Bergman; Daniel J Zaccaro; Richard M Watanabe; Steven M Haffner; Mohammed F Saad; Jill M Norris; Lynne E Wagenknecht; James E Hokanson; Jerome I Rotter; Steven S Rich
Journal:  Diabetes       Date:  2003-08       Impact factor: 9.461

6.  Dose-dependent effects of oral and intravenous glucose on insulin secretion and clearance in normal humans.

Authors:  H Tillil; E T Shapiro; M A Miller; T Karrison; B H Frank; J A Galloway; A H Rubenstein; K S Polonsky
Journal:  Am J Physiol       Date:  1988-03

7.  Influence of treatment with acarbose or glibenclamide on insulin sensitivity in type 2 diabetic patients.

Authors:  S Fischer; A Patzak; H Rietzsch; U Schwanebeck; C Köhler; J Wildbrett; K Fuecker; T Temelkova-Kurktschiev; M Hanefeld
Journal:  Diabetes Obes Metab       Date:  2003-01       Impact factor: 6.577

8.  Glucose clamp technique: a method for quantifying insulin secretion and resistance.

Authors:  R A DeFronzo; J D Tobin; R Andres
Journal:  Am J Physiol       Date:  1979-09

9.  Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance.

Authors:  Rita Basu; Elena Breda; Ann L Oberg; Claudia C Powell; Chiara Dalla Man; Ananda Basu; Janet L Vittone; George G Klee; Puneet Arora; Michael D Jensen; Gianna Toffolo; Claudio Cobelli; Robert A Rizza
Journal:  Diabetes       Date:  2003-07       Impact factor: 9.461

Review 10.  Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach.

Authors:  R N Bergman
Journal:  Diabetes       Date:  1989-12       Impact factor: 9.461

View more
  28 in total

1.  Exercise for obese youth: refocusing attention from weight loss to health gains.

Authors:  Gabriel Q Shaibi; Justin R Ryder; Joon Young Kim; Estela Barraza
Journal:  Exerc Sport Sci Rev       Date:  2015-01       Impact factor: 6.230

2.  Limitations in surrogate measures of insulin resistance.

Authors:  Thomas A Buchanan; Richard M Watanabe; Anny H Xiang
Journal:  J Clin Endocrinol Metab       Date:  2010-11       Impact factor: 5.958

3.  Acute effect of 30 min of accumulated versus continuous brisk walking on insulin sensitivity in young Asian adults.

Authors:  Mei Chan Yap; Govindasamy Balasekaran; Stephen F Burns
Journal:  Eur J Appl Physiol       Date:  2015-04-17       Impact factor: 3.078

4.  Hoofbeats, zebras, and insights into insulin resistance.

Authors:  Robert A Hegele; Karen Reue
Journal:  J Clin Invest       Date:  2009-02       Impact factor: 14.808

5.  Persistent apparent pancreatic β-cell defects in premenarchal PCOS relatives.

Authors:  Laura C Torchen; Naomi R Fogel; Wendy J Brickman; Rodis Paparodis; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2014-07-16       Impact factor: 5.958

6.  Hyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance.

Authors:  M C Amato; R Vesco; E Vigneri; A Ciresi; C Giordano
Journal:  J Endocrinol Invest       Date:  2015-08-21       Impact factor: 4.256

7.  Response heterogeneity to lifestyle intervention among Latino adolescents.

Authors:  Armando Peña; Daniel McNeish; Stephanie L Ayers; Micah L Olson; Kiley B Vander Wyst; Allison N Williams; Gabriel Q Shaibi
Journal:  Pediatr Diabetes       Date:  2020-10-08       Impact factor: 4.866

Review 8.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

9.  Pharmacogenetics of Anti-Diabetes Drugs.

Authors:  Johanna K Distefano; Richard M Watanabe
Journal:  Pharmaceuticals (Basel)       Date:  2010-08-01

10.  Portal glucose infusion-glucose clamp measures hepatic influence on postprandial systemic glucose appearance as well as whole body glucose disposal.

Authors:  Dan Zheng; Viorica Ionut; Vahe Mooradian; Darko Stefanovski; Richard N Bergman
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-11-24       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.